Related Experiment Video
Updated: Apr 24, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
p57Kip2 is an unrecognized DNA damage response effector molecule that functions in tumor suppression and
H Jia1, Q Cong1, J F L Chua2
1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
The DNA damage response (DDR) helps to maintain genome integrity, suppress tumorigenesis and mediate the radiotherapeutic and chemotherapeutic effects on cancer. Here we report that p57Kip2, a cyclin-dependent kinase (CDK) inhibitor implicated in the development of tumor-prone Beckwith-Wiedemann syndrome, is an effector molecule of the DNA-damage response. Genotoxic stress induces p57Kip2 expression via the bone morphogenetic protein-Smad1 and Atm-p38MAPK-Atf2 pathways in p53-proficient or -deficient cells and requires the Smad1-Atf2 complex that facilitates their recruitment to the p57Kip2 promoter. Elevated p57Kip2 induces G1/S phase cell cycle arrest but inhibits cell death in response to DNA damage and acts in parallel with p53 to suppress cell transformation and tumor formation. p57Kip2 is also upregulated in stage I and II clinical rectal tumor samples, likely due to genome instability of precancerous and/or early cancer cells. Targeting p57Kip2 in primary rectal cancer cells and tumor models resulted in increased sensitivity to doxorubicin, suggesting that p57Kip2 has a role in chemoresistance, which is consistent with its pro-survival function. These findings place p57Kip2 in DDR and uncover molecular mechanisms by which p57Kip2 suppresses tumorigenesis and causes chemoresistance.
Insights
The DNA damage response (DDR) involves p57Kip2, a CDK inhibitor. This molecule suppresses tumor formation and contributes to chemoresistance by inhibiting cell death following DNA damage.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- The DNA damage response (DDR) is crucial for maintaining genomic stability and mediating cancer treatment efficacy.
- p57Kip2, a cyclin-dependent kinase (CDK) inhibitor, is linked to Beckwith-Wiedemann syndrome, a condition predisposing to tumors.
Purpose of the Study:
- To investigate the role of p57Kip2 as an effector molecule in the DNA damage response.
- To elucidate the molecular pathways regulating p57Kip2 expression under genotoxic stress.
- To determine the function of p57Kip2 in cell cycle regulation, cell death, and tumor suppression.
Main Methods:
- Investigated p57Kip2 expression induction via BMP-Smad1 and Atm-p38MAPK-Atf2 pathways.
- Analyzed the role of the Smad1-Atf2 complex in p57Kip2 promoter recruitment.
- Assessed the impact of elevated p57Kip2 on cell cycle progression and apoptosis.
- Examined p57Kip2 expression in clinical rectal tumor samples.
- Evaluated the effect of targeting p57Kip2 on chemoresistance in rectal cancer models.
Main Results:
- Genotoxic stress induces p57Kip2 expression through specific signaling pathways, requiring the Smad1-Atf2 complex.
- Elevated p57Kip2 causes G1/S cell cycle arrest but inhibits DNA damage-induced cell death.
- p57Kip2 functions in parallel with p53 to suppress cell transformation and tumor formation.
- p57Kip2 is upregulated in early-stage rectal tumors.
- Inhibition of p57Kip2 increases sensitivity to doxorubicin in rectal cancer cells, indicating a role in chemoresistance.
Conclusions:
- p57Kip2 is a novel effector of the DNA damage response.
- p57Kip2 suppresses tumorigenesis through cell cycle arrest and inhibition of apoptosis.
- p57Kip2 contributes to chemoresistance in rectal cancer, suggesting therapeutic targeting potential.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes

